Leaderboards/Neurofibromatosis and Schwannoma Cases

Neurofibromatosis and Schwannoma Cases

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Dana K. Mitchell
Indiana University – Purdue University Indianapolis
2
Anton Safonov
Memorial Sloan Kettering Cancer Center
3
Thomas R. W. Oliver
Cambridge University Hospitals NHS Foundation Trust
4
Jiawan Wang
Johns Hopkins University
5
Junguang Liao
Zhejiang Sci-Tech University
6
Adam P. Jones
Harvard University
7
Franceska Kovaci
Inserm
8
Paige H. Parrack
Oklahoma City University
9
Helena Mazuelas
Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol
10
Jordan L. Kohlmeyer
University of Iowa

Papers

1
Publication in JCI Insight (2024) [9 citations, W4390579010]
JCI Insight|2024
9 cit.
2
Cancer-independent somatic mutation of the wild-type NF1 allele in normal tissues in neurofibromatosis type 1
Nature Genetics|2025
8 cit.
3
Publication in Nature Communications (2025) [7 citations, W4408847575]
Nature Communications|2025
7 cit.
4
Publication in Molecular Medicine (2025) [2 citations, W4414597519]
Molecular Medicine|2025
2 cit.
5
Publication in Clinical Cancer Research (2025) [1 citation, W4408286455]
Clinical Cancer Research|2025
1 cit.
6
Publication in International Journal of Molecular Sciences (2026) [1 citation, W7124958089]
International Journal of Molecular Sciences|2026
1 cit.
7
OTP Expression in Pulmonary and Thymic Neuroendocrine Neoplasms
The American Journal of Surgical Pathology|2024
0 cit.
8
Publication (2025) [W4416629619]
Unknown Journal|2025
0 cit.
9
Publication (2025) [W4416629663]
Unknown Journal|2025
0 cit.
10
Publication (2025) [W4416629673]
Unknown Journal|2025
0 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Yun-Shao Sung
Memorial Sloan Kettering Cancer Center
2
Joerg-Christian Tonn
LMU Klinikum
3
Christine A. Pratilas
Johns Hopkins University
4
Jessica L. Davis
Indiana University School of Medicine
5
Tiemo J. Klisch
Baylor College of Medicine
6
Christine Chevreau
Institut universitaire du cancer de Toulouse Oncopole
7
Sara J.C. Gosline
Pacific Northwest National Laboratory
8
Jack F. Shern
National Institutes of Health
9
Lisa E. Hang
National Comprehensive Cancer Network
10
David R. Raleigh
University of California, San Francisco

Papers

1
NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022
Journal of the National Comprehensive Cancer Network|2022
398 cit.
2
Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities
Nature Genetics|2022
302 cit.
3
NCCN Guidelines® Insights: Gastrointestinal Stromal Tumors, Version 2.2022
Journal of the National Comprehensive Cancer Network|2022
129 cit.
4
Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses
Nature Medicine|2023
106 cit.
5
Hypermitotic meningiomas harbor DNA methylation subgroups with distinct biological and clinical features
Neuro-Oncology|2022
71 cit.
6
Spatial genomic, biochemical and cellular mechanisms underlying meningioma heterogeneity and evolution
Nature Genetics|2024
55 cit.
7
Targeting farnesylation as a novel therapeutic approach in HRAS-mutant rhabdomyosarcoma
Oncogene|2022
41 cit.
8
Radiotherapy and radiosurgery for meningiomas
Neuro-Oncology Advances|2023
36 cit.
9
Intratumor and informatic heterogeneity influence meningioma molecular classification
Acta Neuropathologica|2022
33 cit.
10
Epigenetic reprogramming shapes the cellular landscape of schwannoma
Nature Communications|2024
29 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
David H. Gutmann
Washington University in St. Louis
2
Nancy Ratner
Cincinnati Children's Hospital Medical Center
3
D. Gareth Evans
Manchester Academic Health Science Centre
4
Francis S. Collins
National Human Genome Research Institute
5
Luis F. Parada
Memorial Sloan Kettering Cancer Center
6
Brigitte C. Widemann
National Cancer Institute
7
Jan M. Friedman
University of British Columbia Hospital
8
Christopher D.�M. Fletcher
Brigham and Women's Hospital
9
Andreas von Deimling
German Cancer Research Center
10
Kathryn N. North
The University of Melbourne

Papers

1
Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project
Nature|2007
5.3k cit.
2
Identification of the Cystic Fibrosis Gene: Chromosome Walking and Jumping
Science|1989
3.2k cit.
3
World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone
Lund University Publications (Lund University)|2002
2.8k cit.
4
A restricted cell population propagates glioblastoma growth after chemotherapy
Nature|2012
2.3k cit.
5
Genome sequence of the Brown Norway rat yields insights into mammalian evolution
Nature|2004
2.2k cit.
6
Recurrent de novo point mutations in lamin A cause Hutchinson–Gilford progeria syndrome
Nature|2003
2.2k cit.
7
The Path to Personalized Medicine
New England Journal of Medicine|2010
1.9k cit.
8
Policy: NIH to balance sex in cell and animal studies
Nature|2014
1.8k cit.
9
A vision for the future of genomics research
Nature|2003
1.7k cit.
10
Type 1 Neurofibromatosis Gene: Identification of a Large Transcript Disrupted in Three NF1 Patients
Science|1990
1.5k cit.

Reagents for Neurofibromatosis and Schwannoma Cases

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

Cell Signaling Technology

Neurofibromin 1 (D7R7D) Rabbit Monoclonal Antibody

Cited in 8 papers
#14623$161,351
View Evidence →

⭐ Top Rated

Best all-around

Cell Signaling Technology

Active Rho Detection Kit

Cited in 6 papers
#8820$1,035
View Evidence →
Agilent/Dako

CD 117 (c-Kit, SCF-Receptor)

Cited in 5 papers
#A4502
View Evidence →
Cell Signaling Technology

PathScan® Phospho-EGF Receptor (Tyr1068) Sandwich ELISA Kit

Cited in 5 papers
#7240$66,129,740
View Evidence →

🌟 All-Time

Most validated

Millipore

Anti-Histone H3.3 Antibody, K27M mutant

Cited in 10 papers
#ABE419
View Evidence →
Cell Signaling Technology

Neurofibromin 1 (D7R7D) Rabbit Monoclonal Antibody

Cited in 8 papers
#14623$161,351
View Evidence →
Cell Signaling Technology

PathScan® Total Stat3 Sandwich ELISA Kit

Cited in 7 papers
#7305$66,129,740
View Evidence →